Austria Infection Control Market Size, Share, Opportunities, COVID-19 Impact, And Trends By Product (Disinfectants, Sterilization (Low-Temperature Sterilization, Heat Sterilization, Contract Sterilization)), By End User Industry (Healthcare, Food And Beverage, Chemical) - Forecasts From 2022 To 2027

The Austrian infection control market is projected to grow at a compound annual growth rate of 6.04% over the forecast period to attain a market size of US$222.134 million in 2027, from US$147.298 million in 2020.  The Austria infection control market is expected to reach new heights during the projected period as a result of the growing engagement in the tourism industry. The increasing engagement in the tourism sector is poised to drive the Austria infection control market to new heights during the forecast period. To this end, around 66,420 accommodation facilities were registered in 2018, an increase of 1,590 facilities from 64,830 accommodation facilities. Furthermore, for the year 2018, there were 149,819,382 overnight stays registered, which increased to 153 million overnight stays with 46 million guests in 2019. Without considering private accommodation, Austria’s tourism intensity is 14.4 overnight stays per inhabitant.[Source: STATcube – Statistical Database of STATISTICS AUSTRIA, Bundesanstalt Statistik Österreich]. This catapults Austria into fourth place in an EU comparison. Thus, along with the aspects mentioned above contributing to the burgeoning tourism industry, it paves the way for the proliferation of the food and beverage segment. This translates to the imperative of establishments, and thus the entire tourism sector, to integrate safe and full-proof infection prevention and control measures to prevent any unwanted cross-contamination. Furthermore, it prevents any spoilage, thus preventing any loss of revenue as well. These developments are expected to propel the growth of the Austria infection control market.

The country's healthcare expenditure and other integral aspects pertaining to healthcare are also the prime factors that are poised to propel the infection control market in Austria to an unprecedented height during the forecast period. In 2018, public current expenditure on health amounted to €29 725 million, or a share of 74.7% of all current healthcare spending. Considering public gross capital formation, public expenditure amounted to €31,156 million. The biggest share of general government expenditure on health (45.8%) in 2018 was spent on inpatient care (including inpatient long-term care). The other main spending categories were outpatient care (26.5%), pharmaceutical products, medical durables and non-durables (13.5%), and home-based health care (8.0%). Considering the period from 2004 to 2018, public current health expenditure rose from €17 267 million to €29 725 million, corresponding to an average annual growth rate of 4.0%. On the other hand, private households and private insurance enterprises spent €9 348 million on health care. With a share of 31.3%, the largest expenditure category of private households and private insurance enterprises was outpatient care. Another 28.7% was spent on pharmaceutical products, medical durables, and non-durables, while the third-largest share (28.3%) was allocated to inpatient care. 7.7% was spent on health administration, and 2.2% on home-based health care, among others. In 2018, the health expenditure in Austria accounted for €39 791 million or 10.3% of gross domestic product (GDP) and places Austria on rank 10 of the top spending countries for health across the OECD. of which €12 032 million (30.2%) were borne by central, state and local governments and another €17 693 million (44.5%) by social health insurance [Source: STATISTIK AUSTRIA, Bundesanstalt Statistik Österreich]. Therefore, from those mentioned earlier, it is discerned that there the healthcare environment is conducive to the rapid growth of the Austria Infection Control Market during the forecast period.

COVID-19 SCENARIO

The need for sterilization and disinfection in hospitals and clinics increases during COVID-19. Technological developments in sterilization & disinfection equipment, an increase in hospitals outsourcing sterilization services, and the production of medical nonwovens, and single-use products due to an increase in COVID-19 cases are all expected to contribute to the growth of the Austria infection control market. The market for infection control is likely to rise, but it will be constrained by the negative effects of chemical disinfectants and worries about the safety of reprocessed devices. On the other hand, during the forecast period, increased use of single-use medical nonwovens and devices is anticipated to present profitable prospects.

Key Development

• October 2020- Industry-leading manufacturer 3M has announced that Belimed Steam Sterilizers are compatible with crisis strategy decontamination of particular single-use N95 respirators. Due to its excellent microbiocidal efficiency, even in the presence of residual soils, this standard steam sterilization procedure is advantageous for assessing and validating compatibility because it is the gold standard among decontamination technologies. It is safe to use due to the absence of harmful residues, simple to administer, and costs little to process, requiring only water and power.

Austria Infection Control Market Scope:

Segmentation

• By Product
  • Disinfectants
  • Sterilization
    • Low-Temperature Sterilization
    • Heat Sterilization
    • Contract Sterilization
• By End User Industry
  • Healthcare
  • Food and Beverage
  • Chemical